Stanley B. Garbus, MD, MPH is a recognized leader in the pharmaceutical industry with over 30 years experience across all phases of clinical research, drug safety, and pharmacovigilance. He has held senior executive positions in pharmacovigilance, medical affairs, and clinical research with Hoffmann-La Roche Inc., Boehringer Ingelheim Pharmaceuticals, Lederle Laboratories, Astra Pharmaceuticals, and several Contract Research Organizations. In 1995, he co-founded Sentrx (Global Safety Surveillance, Inc), a leading provider of technology-enabled solutions and services for global drug safety. His achievements include developing pharmacovigilance training courses, implementing, managing, and reengineering adverse event tracking systems, providing crisis management consulting services, including FDA Class I recalls and FDA-mandated corrective actions, monitoring and investigating drug and device failures, adverse events and recalls, and providing medico-legal expertise to the pharmaceutical industry.

Dr Garbus has lectured, led workshops, chaired numerous conferences, and provided in-house pharmaceutical industry staff training in the US, Canada, Europe, Japan, and Israel on Pharmacovigilance, Risk Management, Electronic Submission of NDAs, Drug Safety Surveillance, Crisis Management, Product Liability, and Clinical Project Management. An acknowledged expert in developing and implementing drug safety programs, he has been a frequent speaker and course leader at many conferences and seminars, including the Drug Information Association, the American Academy for Pharmaceutical Physicians, Center for Business Intelligence, American Bar Association, Institute for International Research, Pharmaceutical Training Institute International, and the BioForum Applied Knowledge Center. He is a reviewer for the Journal of Clinical Pharmacology and has authored peer-reviewed scientific articles and on-line medical educational programs.

Dr Garbus received his medical degree from the University of Geneva, Switzerland, completed specialty training in Internal Medicine at the State University of New York, Nassau County Medical Center. He completed his fellowship in Nephrology at Mt Sinai Medical Center, Cleveland OH. He also holds an MPH in Epidemiology from the Yale School of Public Health. As an Assistant Professor of Medicine and Pharmacology, Dr. Garbus taught and directed clinical research at LSU School of Medicine in New Orleans, where he was head of the kidney transplantation program. He was Director of the LSU Medical Center, Hypertension Clinic/Research Laboratory, Co-Director, LSU Renal Transplant Service, Director of the American Heart Association Hypertension Screening and Follow-up Program, New Orleans, and Director, Louisiana State Hypertension Detection/Referral Program, Regional Medical Programs.